Exhibit 99.1
Consent of Deutsche Bank Securities Inc.
We hereby consent to (i) the inclusion of our opinion letter, dated November 5, 2013, to the Board of Directors as Annex F to the proxy statement/prospectus forming part of the Amendment No. 1 to the Registration Statement on Form S-4 relating to the proposed transaction involving Endo Health Solutions Inc. and Paladin Labs Inc. (the “Registration Statement”) and (ii) references made to our firm and such opinion in the Registration Statement. In giving such consent, we do not admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, and the rules and regulations of the Securities and Exchange Commission promulgated thereunder, and we do not admit that we are experts with respect to any part of the Registration Statement within the meaning of the term “expert” as used in the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission promulgated thereunder. Additionally, such consent does not cover any amendments to the Registration Statement.
| /s/ Deutsche Bank Securities Inc. |
| DEUTSCHE BANK SECURITIES INC. |
January 24, 2014
